Internship

Vertex Fall 2025 Co-op

Manufacturing Science and Technology, Small Molecule Drug Product

Confirmed live in the last 24 hours

Vertex Pharmaceuticals

Vertex Pharmaceuticals

1,001-5,000 employees

Develops medicines for serious diseases

Compensation Overview

$24 - $35/hr

+ Bonus + Equity Awards

No H1B Sponsorship

Boston, MA, USA

Category
Process Engineering
Required Skills
SolidWorks
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a Vertex Pharmaceuticals referral from your network.

💡

Applications through a referral are 3x more likely to get an interview!

Requirements
  • The candidate should be a Mechanical Engineering Junior, Senior, or Graduate Student.
  • Experience with machine/electro-mechanical design (conceptual) is key in success of the project.
  • Previous experience with custom machinery builds (especially pharmaceutical equipment) is highly desired.
  • Exposure to business-aspects of pharmaceutical manufacturing operations of Continuous Manufacturing equipment would be highly desired.
  • Experience requirements: electro-mechanical design background/previous internships.
  • Critical Skills: high level mastery of 3D CAD program Solidworks, ability to write operational manuals/BOM-type documentation.
  • Legal authorization to work in the United States, now and in the future.
  • Candidate must be enrolled in an advanced degree program if graduating before July 2025.
  • Candidate must be available to work full-time, 40 hours per week from July - December 2025.
Responsibilities
  • Next generation CM activities are in progress, which surround the development of low risk, rapid TechTransfer equipment set up to enable clinical and commercial manufacturing.
  • The key responsibilities of the Co-op will surround the activity of equipment design of a continuous material feeding and blending module.
  • Day-to-day tasks will consist of the development of a design concept (ie 3D Model) of a powder/blend feeding module including material handling and refill systems as well as process mapping and business-oriented documentation which could serve as a base for future detailed vendor engineering studies and potential purchase/implementation of such a system.
  • The design concept and high-level operating philosophy/business case for a commercially-viable rig is the main deliverable of the project.
Desired Qualifications
  • Previous experience with custom machinery builds (especially pharmaceutical equipment) is highly desired.
  • Exposure to business-aspects of pharmaceutical manufacturing operations of Continuous Manufacturing equipment would be highly desired.
Vertex Pharmaceuticals

Vertex Pharmaceuticals

View

Vertex Pharmaceuticals develops medicines for serious diseases, focusing on conditions like cystic fibrosis. The company conducts extensive research and development to create new drugs, often collaborating with other biotech firms to enhance its therapeutic offerings. One of its notable products is ivacaftor, which has shown effectiveness in treating cystic fibrosis. Vertex differentiates itself from competitors through its commitment to scientific innovation and strategic partnerships that expand its research capabilities. The goal of Vertex Pharmaceuticals is to improve the quality of life for patients with severe and life-threatening conditions by bringing effective treatments to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Boston, Massachusetts

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • Vertex's EU approval expands its cystic fibrosis treatment market.
  • Partnerships with Arbor and Orna enhance Vertex's gene therapy capabilities.
  • Increased focus on personalized medicine aligns with Vertex's patient-centric approach.

What critics are saying

  • Increased competition in cystic fibrosis could impact Vertex's market share.
  • Regulatory changes in the EU may delay Vertex's drug approvals.
  • High R&D costs and potential trial failures could strain Vertex's finances.

What makes Vertex Pharmaceuticals unique

  • Vertex focuses on transformative medicines for serious diseases, like cystic fibrosis.
  • The company invests heavily in R&D and strategic partnerships for drug development.
  • Vertex's innovative cell and gene therapies set it apart in the biotech industry.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Company News

Buniversity
May 1st, 2025
VERTEX upset Grayhound for spot at BLAST Showdown

VERTEX locked in a first-place finish at Fortress OCE Masters Fall 2022 Finals in Melbourne to qualify for BLAST Premier Fall Showdown.

BioSpace
Apr 14th, 2025
Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis

Vertex researcher, Paul Negulescu Ph.D., receives the 2025 Canada Gairdner International Award for pioneering Research and discovery of medicines for Cystic Fibrosis.

Biz Owner Daily
Apr 7th, 2025
EU Approves Expanded Label for Vertex Pharmaceuticals' Cystic Fibrosis Treatment

Vertex Pharmaceuticals has received approval from the European Union to broaden the label for its cystic fibrosis treatment.

Slater Sentinel
Mar 23rd, 2025
Stevens Capital Management LP Makes New $829,000 Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Stevens Capital Management LP makes new $829,000 investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX).

Investing.com
Mar 20th, 2025
BMO maintains Vertex stock Market Perform rating and $41 target

The reaffirmation of the rating and target came after Vertex held its first analyst day since its initial public offering in 2020.